Павлов В. Н., Урманцев М. Ф., Хамидуллин Т. Р., Бакеев М. Р. МИКРОБИОМ МОЧЕВОГО ПУЗЫРЯ И РАК МОЧЕВОГО ПУЗЫРЯ. Медицинский вестник Башкортостана. 2024;19(3):75-79.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries / H. Sung [et al.] // CA Cancer J. Clin. – 2021. – Vol. 71. – P. 209-249. doi: 10.3322/caac.21660
2. GLOBOCAN 2022: Bladder cancer 9th most common worldwide [Электронный ресурс]. URL: https://worldbladdercancer.org/news_events/globocan-2022-bladder-cancer-is-the-9th-most-commonly-diagnosed-worldwide/ (date of access 25.04.2024)
3. Inamura, K. Bladder Cancer: New Insights into Its Molecular Pathology / K. Inamura // Cancers. – 2018. – Vol. 10. – P. 100. doi: 10.3390/cancers10040100.
4. Berdik, C. Unlocking bladder cancer / C. Berdik // Nature. – 2017. – Vol. 551. – P. 34-35. doi: 10.1038/551S34a.
5. The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness / C. Andolfi [et al.] // Bladder Cancer. – 2020. – Vol. 6. – P. 225-235. doi: 10.3233/BLC-200277.
6. Wolfe, A.J. “Sterile Urine” and the Presence of Bacteria / A.J. Wolfe, L. Brubaker // Eur. Urol. – 2015. – Vol. 68. – P. 173-174. doi: 10.1016/j.eururo.2015.02.041.
7. Brubaker, L. The urinary microbiota: A paradigm shift for bladder disorders? / L. Brubaker, A. Wolfe // Curr. Opin. Obstet. Gynecol. – 2016. – Vol. 28. – P. 407-412. doi: 10.1097/GCO.0000000000000298.
8. The microbiome and host mucosal interactions in urinary tract diseases / B. Jones-Freeman [et al.] // Mucosal Immunol. – 2021. – Vol. 14. – 779-792. doi: 10.1038/s41385-020-00372-5.
9. El-Deeb, O.S. The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor beta/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective / O.S. El-Deeb, M.M. Atef, Y.M. Hafez // J. Cell. Biochem. – 2019. – Vol. 120. – P. 14476–14485. doi: 10.1002/jcb.28707.
10. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury / D.E. Fouts [et al.] // J. Transl. Med. – 2012. – Vol. 10. – P. 174. doi: 10.1186/1479-5876-10-174.
11. Abernethy, M.G. The bladder microbiome and interstitial cystitis: Is there a connection? / M.G. Abernethy, A. Tsuei // Curr. Opin. Obstet. Gynecol. – 2021. – Vol. 33. – P. 469-473. doi: 10.1097/GCO.0000000000000747
12. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients / F. Pederzoli [et al.] // Eur. Urol. Oncol. – 2020. – Vol. 3. – P. 784-788
13. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury / D.E. Fouts [et al.] // J. Transl. Med. – 2012. – Vol. 10. – P. 174.
14. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants with Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies / B.D. Modena [et al.] // Am. J. Transplant. – 2017. – Vol. 17. – P. 712-723.
15. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment / C. Gottschick [et al.] // Microbiome. – 2017. – Vol. 5. – P. 99. doi: 10.1186/s40168-017-0305-3.
16. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies / FH van Osch [et al.] // Int J Epidemiol. – 2016. – Vol. 45: DOI: 10.1093/ije/dyw044; 867
17. Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? / Ma Wenchao [et al.] // A Retrospective Study. – 2021 DOI: 10.3389/fonc.2021.677605 – 1-3
18. The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer / X. Huang [et al.] // Genes Dis. – 2020, Oct.13. – Vol. 8, N 6. – P.781-797. doi: 10.1016/j.gendis.2020.10.002.
19. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer / N. Nadler [et al.] // APMIS. – 2021. – Vol. 129. – P. 265-270. doi: 10.1111/apm.13097. P. 3-4
20. Role of chronic E. coli infection in the process of bladder cancer- an experimental study / H. El-Mosalamy [et al.] // Infect. Agents Cancer. – 2012. – Vol. 7. – P. 19. doi: 10.1186/1750-9378-7-19.
21. Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC / Y. Guo [et al.] // FASEB J. – 2020. – Vol. 34. – P. 7927-7940.
22. Investigating the association between the urinary microbiome and bladder cancer: An exploratory study / A.A. Hussein [et al.] // Urol. Oncol. Semin. Orig. Investig. – 2021. – Vol. 39. – P. 370.e9–370.e19. doi: 10.1016/j.urolonc.2020.12.011.
23. Urinary microbiota—A potential biomarker and therapeutic target for bladder cancer / H. Bi [et al.] // J. Med. Microbiol. – 2019. – Vol. 68. – P. 1471-1478. doi: 10.1099/jmm.0.001058
24. Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study. / J. Zeng [et al.] // Front. Cell. Infect. Microbiol. – 2020. – Vol. 10. – P. 555508. doi: 10.3389/fcimb.2020.555508.
25. Deciphering the influence of urinary microbiota on FoxP3+ regulatory T cell infiltration and prognosis in Chinese patients with nonmuscle-invasive bladder cancer / Y. Qiu [et al.] // Hum. Cell. – 2022. – Vol. 35. – P. 511-521. doi: 10.1007/s13577-021-00659-0.
26. Profiling the urinary microbiota in male patients with bladder cancer in China / P. Wu [et al.] // Front. Cell. Infect. Microbiol. – 2018. – Vol. 8. – P. 167. doi: 10.3389/fcimb.2018.00167.
27. Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer / R.F. Sweis [et al.] // J. Clin. Oncol. – 2019. – Vol. 37. – P. 423. doi: 10.1200/JCO.2019.37.7_suppl.423
28. The effect of BCG intravesical therapy and recurrence on PDL1 expression in non-invasive bladder cancers / M. Hurwitz [et al.] // J Clin Oncol. – 2015. – Vol. 33. – P. e15504.
29. Urogenital Microbiota: Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer / C. Chen [et al.] // BMC Microbiol. – 2022. – Vol. 22. – P. 7. doi: 10.1186/s12866-021-02407-8.
